A detailed history of American International Group, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, American International Group, Inc. holds 2,208 shares of IONS stock, worth $99,669. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,208
Previous 2,237 1.3%
Holding current value
$99,669
Previous $113,000 15.93%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $1,218 - $1,552
-29 Reduced 1.3%
2,208 $95,000
Q4 2023

Feb 13, 2024

SELL
$43.39 - $51.63 $2,646 - $3,149
-61 Reduced 2.65%
2,237 $113,000
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $6,044 - $7,399
-157 Reduced 6.4%
2,298 $104,000
Q2 2023

Aug 04, 2023

BUY
$34.73 - $43.33 $14,204 - $17,721
409 Added 19.99%
2,455 $100,000
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $2,014 - $2,472
-60 Reduced 2.85%
2,046 $73,000
Q4 2022

Feb 10, 2023

SELL
$37.12 - $46.52 $1,744 - $2,186
-47 Reduced 2.18%
2,106 $79,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $219 - $291
6 Added 0.28%
2,153 $95,000
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $13,349 - $18,103
-421 Reduced 16.39%
2,147 $79,000
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $89 - $111
-3 Reduced 0.12%
2,568 $95,000
Q4 2021

Feb 11, 2022

SELL
$25.61 - $35.1 $2,279 - $3,123
-89 Reduced 3.35%
2,571 $78,000
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $6,976 - $8,434
-208 Reduced 7.25%
2,660 $89,000
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $21,863 - $29,909
633 Added 28.32%
2,868 $114,000
Q1 2021

May 07, 2021

SELL
$42.51 - $63.78 $10,159 - $15,243
-239 Reduced 9.66%
2,235 $100,000
Q4 2020

Feb 12, 2021

SELL
$45.3 - $60.27 $3,261 - $4,339
-72 Reduced 2.83%
2,474 $140,000
Q3 2020

Nov 04, 2020

SELL
$47.45 - $62.95 $3,748 - $4,973
-79 Reduced 3.01%
2,546 $121,000
Q2 2020

Aug 12, 2020

SELL
$46.85 - $61.05 $13,352 - $17,399
-285 Reduced 9.79%
2,625 $155,000
Q1 2020

May 04, 2020

SELL
$41.6 - $63.4 $3,827 - $5,832
-92 Reduced 3.06%
2,910 $138,000
Q4 2019

Feb 05, 2020

SELL
$53.85 - $65.27 $6,838 - $8,289
-127 Reduced 4.06%
3,002 $181,000
Q2 2019

Aug 13, 2019

BUY
$62.09 - $86.14 $13,225 - $18,347
213 Added 7.3%
3,129 $201,000
Q1 2019

May 06, 2019

SELL
$52.92 - $81.17 $5,450 - $8,360
-103 Reduced 3.41%
2,916 $237,000
Q2 2018

Aug 08, 2018

BUY
$40.53 - $50.7 $8,187 - $10,241
202 Added 7.17%
3,019 $126,000
Q1 2018

May 07, 2018

SELL
$44.08 - $55.05 $4,760 - $5,945
-108 Reduced 3.69%
2,817 $124,000
Q4 2017

Feb 09, 2018

BUY
$50.3 - $64.39 $147,127 - $188,340
2,925
2,925 $147,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.